-
Je něco špatně v tomto záznamu ?
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-Dupas, R. Murray, GL. Onorato, JL. Pépin, R. Picard, F. Portejoie, E. Costa, J. Fonseca, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, AA. Cruz, J. da Silva, FS. Serpa, M....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
BioMedCentral
od 2011-12-01 do 2020-12-31
BioMedCentral Open Access
od 2011
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2015-01-01
Wiley-Blackwell Open Access Titles
od 2011
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01 do 2020-12-31
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Service University Hospital of Federal University of Santa Catarina Florianópolis Brazil
Allergy Unit Department of Dermatology University Hospital of Zurich Zürich Switzerland
AQuAS Barcelona Spain EUREGHA European Regional and Local Health Association Brussels Belgium
Association of Finnish Pharmacists Helsinki Finland
Center of Excellence in Asthma and Allergy Hospital Médica Sur México City Mexico
Centre for Clinical Research Sörmland Uppsala University Eskilstuna Sweden
CIRFF Federico 2 University Naples Italy
Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania
Conseil Général de l'Economie Ministère de l'Economie de l'Industrie et du Numérique Paris France
Consortium of Pharmacies and Services COSAFER Salerno Italy
Department of Clinical Science and Education Karolinska Institutet Södersjukhuset Stockholm Sweden
Department of ENT Medical University of Graz Graz Austria
Department of Internal Medicine Medical University of Graz Graz Austria
Department of Medicine Clinical Immunology and Allergy McMaster University Hamilton ON Canada
Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands
Department of Otorhinolaryngology Chiba University Hospital Chiba Japan
Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece
Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
Department of Pulmonary Diseases Cerrahpasa Faculty of Medicine Istanbul University Istanbul Turkey
Department of Respiratory Diseases Montpellier University Hospital Montpellier France
Division of Allergy Immunology University of South Florida Tampa USA
EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
Faculty of Medicine Transylvania University Brasov Romania
Faculty of Medicine Vilnius University Vilnius Lithuania
iQ4U Consultants Ltd London UK
ISGlobAL Centre for Research in Environmental Epidemiology Barcelona Spain
Johns Hopkins School of Medicine Baltimore MD USA
KYomed INNOV Montpellier France
MedScript Ltd Dundalk Co Louth Ireland
Nova Southeastern University Fort Lauderdale Florida USA
Peercode BV Geldermalsen The Netherlands
Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis MO USA
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
Universidad Católica de Córdoba Córdoba Argentina
University Hospital Olomouc Olomouc Czech Republic
Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001589
- 003
- CZ-PrNML
- 005
- 20190118104135.0
- 007
- ta
- 008
- 190107s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13601-018-0227-6 $2 doi
- 035 __
- $a (PubMed)30386555
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bousquet, J $u MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France. INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France. Euforea, Brussels, Belgium.
- 245 10
- $a MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence / $c J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-Dupas, R. Murray, GL. Onorato, JL. Pépin, R. Picard, F. Portejoie, E. Costa, J. Fonseca, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, AA. Cruz, J. da Silva, FS. Serpa, M. Illario, E. Menditto, L. Cecchi, R. Monti, L. Napoli, MT. Ventura, G. De Feo, D. Larenas-Linnemann, M. Fuentes Perez, YR. Huerta Villabolos, D. Rivero-Yeverino, E. Rodriguez-Zagal, F. Amat, I. Annesi-Maesano, I. Bosse, P. Demoly, P. Devillier, JF. Fontaine, J. Just, TP. Kuna, B. Samolinski, A. Valiulis, R. Emuzyte, V. Kvedariene, D. Ryan, A. Sheikh, P. Schmidt-Grendelmeier, L. Klimek, O. Pfaar, KC. Bergmann, R. Mösges, T. Zuberbier, RE. Roller-Wirnsberger, P. Tomazic, WJ. Fokkens, NH. Chavannes, S. Reitsma, JM. Anto, V. Cardona, T. Dedeu, J. Mullol, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, B. Gemicioğlu, A. Yorgancioglu, N. Papadopoulos, EP. Prokopakis, S. Bosnic-Anticevich, R. O'Hehir, JC. Ivancevich, H. Neffen, E. Zernotti, I. Kull, E. Melen, M. Wickman, C. Bachert, P. Hellings, S. Palkonen, C. Bindslev-Jensen, E. Eller, S. Waserman, M. Sova, G. De Vries, M. van Eerd, I. Agache, T. Casale, M. Dykewickz, RN. Naclerio, Y. Okamoto, DV. Wallace, . ,
- 520 9_
- $a mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Arnavielhe, S $u KYomed-INNOV, Montpellier, France.
- 700 1_
- $a Bedbrook, A $u MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
- 700 1_
- $a Bewick, M $u iQ4U Consultants Ltd, London, UK.
- 700 1_
- $a Laune, D $u KYomed-INNOV, Montpellier, France.
- 700 1_
- $a Mathieu-Dupas, E $u KYomed-INNOV, Montpellier, France.
- 700 1_
- $a Murray, R $u MedScript Ltd, Dundalk, Co Louth Ireland.
- 700 1_
- $a Onorato, G L $u MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
- 700 1_
- $a Pépin, J L $u 7Laboratoire HP2, Grenoble, INSERM, U1042, Université Grenoble Alpes, Grenoble, France. 8CHU de Grenoble, Grenoble, France.
- 700 1_
- $a Picard, R $u Conseil Général de l'Economie Ministère de l'Economie, de l'Industrie et du Numérique, Paris, France.
- 700 1_
- $a Portejoie, F $u MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
- 700 1_
- $a Costa, E $u 10UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing), Porto, Portugal.
- 700 1_
- $a Fonseca, J $u 11Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal. Medida, Lda, Porto, Portugal.
- 700 1_
- $a Lourenço, O $u 13Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
- 700 1_
- $a Morais-Almeida, M $u Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
- 700 1_
- $a Todo-Bom, A $u 15Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
- 700 1_
- $a Cruz, A A $u 16ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Vitória da Conquista, Brazil. WHO GARD Planning Group, Salvador, Brazil.
- 700 1_
- $a da Silva, J $u 18Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil.
- 700 1_
- $a Serpa, F S $u 19Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria, Vitória, Esperito Santo Brazil.
- 700 1_
- $a Illario, M $u Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
- 700 1_
- $a Menditto, E $u 21CIRFF, Federico II University, Naples, Italy.
- 700 1_
- $a Cecchi, L $u SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
- 700 1_
- $a Monti, R $u 23Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy.
- 700 1_
- $a Napoli, L $u Consortium of Pharmacies and Services COSAFER, Salerno, Italy.
- 700 1_
- $a Ventura, M T $u 25Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
- 700 1_
- $a De Feo, G $u 26Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
- 700 1_
- $a Larenas-Linnemann, D $u 27Center of Excellence in Asthma and Allergy, Hospital Médica Sur, México City, Mexico.
- 700 1_
- $a Fuentes Perez, M $u Mexico City, Mexico.
- 700 1_
- $a Huerta Villabolos, Y R $u Mexico City, Mexico.
- 700 1_
- $a Rivero-Yeverino, D $u Puebla, Puebla Mexico.
- 700 1_
- $a Rodriguez-Zagal, E $u Ciutad Mexico, Mexico.
- 700 1_
- $a Amat, F $u 31Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France. 32UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universités, Equipe EPAR, 75013 Paris, France.
- 700 1_
- $a Annesi-Maesano, I $u 33Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, UPMC Sorbonne Université, Medical School Saint Antoine, Paris, France.
- 700 1_
- $a Bosse, I $u La Rochelle, France.
- 700 1_
- $a Demoly, P $u 35Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
- 700 1_
- $a Devillier, P $u 36UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
- 700 1_
- $a Fontaine, J F $u Reims, France.
- 700 1_
- $a Just, J $u 31Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France. 32UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universités, Equipe EPAR, 75013 Paris, France.
- 700 1_
- $a Kuna, T P $u 38Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
- 700 1_
- $a Samolinski, B $u 39Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
- 700 1_
- $a Valiulis, A $u 40Clinic of Children's Diseases, and Institute of Health Sciences Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania. European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
- 700 1_
- $a Emuzyte, R $u 42Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- 700 1_
- $a Kvedariene, V $u 43Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- 700 1_
- $a Ryan, D $u Woodbrook Medical Centre, Loughborough, UK. 45Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Medical School, Edinburgh, UK.
- 700 1_
- $a Sheikh, A $u 46Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
- 700 1_
- $a Schmidt-Grendelmeier, P $u 47Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zürich, Switzerland.
- 700 1_
- $a Klimek, L $u Center for Rhinology and Allergology, Wiesbaden, Germany. 49Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- 700 1_
- $a Pfaar, O $u Center for Rhinology and Allergology, Wiesbaden, Germany. 49Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- 700 1_
- $a Bergmann, K C $u 50Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany. Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
- 700 1_
- $a Mösges, R $u 52Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany. CRI-Clinical Research International-Ltd, Hamburg, Germany.
- 700 1_
- $a Zuberbier, T $u 50Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany. Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
- 700 1_
- $a Roller-Wirnsberger, R E $u 54Department of Internal Medicine, Medical University of Graz, Graz, Austria.
- 700 1_
- $a Tomazic, P $u 55Department of ENT, Medical University of Graz, Graz, Austria.
- 700 1_
- $a Fokkens, W J $u 56Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
- 700 1_
- $a Chavannes, N H $u 57Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
- 700 1_
- $a Reitsma, S $u 56Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
- 700 1_
- $a Anto, J M $u ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. 59IMIM (Hospital del Mar Research Institute), Barcelona, Spain. 60CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. 61Universitat Pompeu Fabra (UPF), Barcelona, Spain.
- 700 1_
- $a Cardona, V $u 62Allergy Section, Department of Internal Medicine, Hospital Vall 'dHebron & ARADyAL Research Network, Barcelona, Spain.
- 700 1_
- $a Dedeu, T $u 63AQuAS, Barcelona, Spain. EUREGHA, European Regional and Local Health Association, Brussels, Belgium.
- 700 1_
- $a Mullol, J $u 65Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, University of Barcelona, Barcelona, Spain. 66Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
- 700 1_
- $a Haahtela, T $u 67Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
- 700 1_
- $a Salimäki, J $u Association of Finnish Pharmacists, Helsinki, Finland.
- 700 1_
- $a Toppila-Salmi, S $u 67Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
- 700 1_
- $a Valovirta, E $u 69Department of Lung Diseases and Clinical Immunology, University of Turku, Turku, Finland. Terveystalo Allergy Clinic, Turku, Finland.
- 700 1_
- $a Gemicioğlu, B $u 71Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Yorgancioglu, A $u 72Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey. GARD Executive Committee, Manisa, Turkey.
- 700 1_
- $a Papadopoulos, N $u 74Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK. 75Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, 11527 Athens, Greece.
- 700 1_
- $a Prokopakis, E P $u 76Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece.
- 700 1_
- $a Bosnic-Anticevich, S $u Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
- 700 1_
- $a O'Hehir, R $u 78Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia. 79Department of Immunology, Monash University, Melbourne, VIC Australia.
- 700 1_
- $a Ivancevich, J C $u Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
- 700 1_
- $a Neffen, H $u Director of Center of Allergy, Immunology and Respiratory Diseases, Santa Fe, Argentina Center for Allergy and Immunology, Santa Fe, Argentina.
- 700 1_
- $a Zernotti, E $u 82Universidad Católica de Córdoba, Córdoba, Argentina.
- 700 1_
- $a Kull, I $u 83Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
- 700 1_
- $a Melen, E $u 84Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden. 85Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Wickman, M $u 86Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.
- 700 1_
- $a Bachert, C $u 87Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
- 700 1_
- $a Hellings, P $u Euforea, Brussels, Belgium. 88Department of Otorhinolaryngology, Univ Hospitals Leuven, Louvain, Belgium. 89Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a Palkonen, S $u 90EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
- 700 1_
- $a Bindslev-Jensen, C $u Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
- 700 1_
- $a Eller, E $u Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
- 700 1_
- $a Waserman, S $u 92Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, ON Canada.
- 700 1_
- $a Sova, M $u 93University Hospital Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a De Vries, G $u Peercode BV, Geldermalsen, The Netherlands.
- 700 1_
- $a van Eerd, M $u Peercode BV, Geldermalsen, The Netherlands.
- 700 1_
- $a Agache, I $u 95Faculty of Medicine, Transylvania University, Brasov, Romania.
- 700 1_
- $a Casale, T $u 96Division of Allergy/Immunology, University of South Florida, Tampa, USA.
- 700 1_
- $a Dykewickz, M $u 97Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, MO USA.
- 700 1_
- $a Naclerio, R N $u 98Johns Hopkins School of Medicine, Baltimore, MD USA.
- 700 1_
- $a Okamoto, Y $u 99Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
- 700 1_
- $a Wallace, D V $u 100Nova Southeastern University, Fort Lauderdale, Florida USA.
- 700 1_
- $a ,
- 773 0_
- $w MED00188032 $t Clinical and translational allergy $x 2045-7022 $g Roč. 8, č. - (2018), s. 45
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30386555 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190118104349 $b ABA008
- 999 __
- $a ind $b bmc $g 1365401 $s 1039712
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 8 $c - $d 45 $e 20181025 $i 2045-7022 $m Clinical and translational allergy $n Clin Transl Allergy $x MED00188032
- LZP __
- $a Pubmed-20190107
